Journals / Türk Biyokimya Dergisi / 2019 / Cilt: 44 - Sayı: 5

An evaluation of biomarkers indicating endothelial cell damage, inflammation and coagulation in children with Henoch-Schönlein purpura

Henoch-Schönlein Purpura’lı çocuklarda endotel disfonksiyonu, inflamasyon ve koagülasyon biyobelirteçlerinin değerlendirilmesi

Pages
676–682
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Serum endocan levels in patients with HSP were inversely correlated only with activated partialthromboplastin time (APTT) (r = −0.485, p = 0.012).Conclusion: Coagulation abnormalities and increasedacute phase reactants were present in patients with HSPwhile no difference was determined in endocan levels.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:AbstractObjective: Henoch-Schönlein purpura (HSP) is characterized by generalized vasculitis.
📊
Key Findings & Data:Therefore, herein we investigated serum levels of biomarkers indicating endothelial cell damage, inflammation and coagulation in children with HSP.Materials and methods: Twenty six patients with HSP and 26 healthy children were included in the study.
💡
Conclusion & Impact:Serum endocan levels in patients with HSP were inversely correlated only with activated partialthromboplastin time (APTT) (r = −0.485, p = 0.012).Conclusion: Coagulation abnormalities and increasedacute phase reactants were present in patients with HSPwhile no difference was determined in endocan levels.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

AbstractObjective: Henoch-Schönlein purpura (HSP) is characterized by generalized vasculitis. The etiopathogenesis of the disease is unknown, but inflammation and endothelial dysfunction have been held responsible. Therefore, herein we investigated serum levels of biomarkers indicating endothelial cell damage, inflammation and coagulation in children with HSP.Materials and methods: Twenty six patients with HSP and 26 healthy children were included in the study. Routine biochemical tests and laboratory parameters showing inflammation, coagulation, and endothelial cell damage were examined in all subjects.Results: White blood cell (WBC) number, C-reactive protein (CRP) level, erythrocyte sedimentation rate (ESR), neutrophil/lymphocyte rate (NLR), triglyceride, immunoglobulin A (IgA), and C3 were significantly higher in children with HSP than the controls. HDL and albumin levels were lower in the patients with HSP. Endocan levels were not significantly different between the HSP and control groups (p = 0.884). Serum endocan levels in patients with HSP were inversely correlated only with activated partialthromboplastin time (APTT) (r = −0.485, p = 0.012).Conclusion: Coagulation abnormalities and increasedacute phase reactants were present in patients with HSPwhile no difference was determined in endocan levels.

Özet

Öz Amaç: Henoch-Schönlein purpurası (HSP) jeneralize vaskülit ile karakterizedir. Hastalığın etiyopatogenezi bilinmemekte olup inflamasyon ve endotelyal disfonksiyon sorumlu tutulmaktadır. Bu nedenle çalışmamızda HSP’li çocuklarda endotel hücre hasarı, inflamasyon ve pıhtılaşmayı belirten bazı biyobelirteçlerin serum düzeyleri araştırılmıştır.Gereç ve Yöntem: Çalışmaya HSP’li 26 hasta ve kontrol grubu olarak 26 sağlıklı çocuk dahil edildi. Tüm olgularda rutin biyokimyasal testler ve inflamasyon, koagülasyon ve endotel hücre hasarını gösteren laboratuvar verileri analiz edildi.Bulgular: HSP’li çocuklarda beyaz kan hücresi (WBC) sayısı, C-reaktif protein (CRP) düzeyi, eritrosit sedimentasyon hızı (ESH), nötrofil/lenfosit (NLR) oranı, trigliserit, immünoglobulin A (IgA) ve C3 kontrol grubundan anlamlı olarak yüksek bulundu. HDL ve albümin düzeyleri ise HSP’li hastalarda daha düşüktü. Endocan düzeyleri açısından gruplar arasında anlamlı farklılık saptanmadı (p = 0.884). Serum endokan düzeyleri sadece aktive parsiyel tromboplastin zamanı (APTT) ile ters korele bulundu (r = −0.485, p = 0.012).Sonuç: HSP’li çocuklarda koagülasyon anormallikleri ve artmış akut faz reaktanları gözlenirken, bir endotel disfonksiyon belirteci olan endokan düzeylerinde anlamlı farklılık saptanmadı.

🔖

Cite This Article

DURU, N. S., ÜSTYOL, A., COŞKUN, C., KOLDAŞ, M., ELEVLİ, M., ŞAHİN, K. (2022). An evaluation of biomarkers indicating endothelial cell damage, inflammation and coagulation in children with Henoch-Schönlein purpura. Türk Biyokimya Dergisi, Cilt: 44 - Sayı: 5, 676–682. https://ajindex.com/articles/620839

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Yang YH, Tsai IJ, Chang CJ, Chuang YH, Hsu HY, Chiang BL. The interaction between circulating complement proteins and cutaneous microvascular endothelial cells in the development of childhood Henoch-Schönlein purpura. PLoS One 2015;10:e0120411
  2. Heineke MH, Ballering AV, Jamin A, Ben Mkaddem S, Monteiro RC, Van Egmond M. New insights in the pathogenesis of immunoglobulin a vasculitis (Henoch-Schönlein purpura). Autoimmun Rev 2017;16:1246–53
  3. De Mattia D, Penza R, Giordano P, Del Vecchio GC, Aceto G, Altomare M, et al. Von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura. Pediatr Nephrol 1995;9:603–5
  4. ButbulAviel Y, Dafna L, Pilar G, Brik R. Endothelial function in children with a history of henochschonleinpurpura. Pediatr Rheumatol Online J 2017;15:3
  5. Brendel-Müller K, Hahn A, Schneppenheim R, Santer R. Laboratory signs of activated coagulation are common in HenochSchönlein purpura. Pediatr Nephrol 2001;16:1084–8
  6. Söylemezoglu O, Sultan N, Gursel T, Buyan N, Hasanoglu E. Circulating adhesion molecules ICAM-1, E-selectin, and von Willebrand factor in Henoch-Schonlein purpura. Arch Dis Child 1996;75:507–11
  7. Hong J, Yang HR. Laboratory markers indicating gastrointestinal involvement of henoch-schönlein purpura in children. Pediatr Gastroenterol Hepatol Nutr 2015;18:39–47
  8. Fessatou S, Nicolaidou P, Gourgiotis D, Georgouli H, Douros K, Moustaki M, et al. Endothelin 1 levels in relation to clinical presentation and outcome of Henoch Schonlein purpura. BMC Pediatr 2008;8:33
  9. Reakatanan W, Kadegasem P, Chunharas A, Tapaneya-Olarn W, Treepongkaruna S, Sirachainan N. High D-dimer Level in Henoch-Schönlein purpura with pancreatitis. Pancreas 2016;45:e4–5
  10. Del Vecchio GC, Penza R, Altomare M, Piacente L, Aceto G, Lassandro G, et al. Cytokine pattern and endothelium damage markers in Henoch-Schönlein purpura. Immunopharmacol Immunotoxicol 2008;30:623–9
  11. Yang J, Yang Q, Yu S, Zhang X. Endocan: a new marker for cancer and a target for cancer therapy. Biomed Rep 2015;3:279–83
  12. Seo K, Kitazawa T, Yoshino Y, Koga I, Ota Y. Characteristics of serum endocan levels in infection. PLoS One 2015;10:e0123358
  13. Balta I, Balta S, Koryurek OM, Demirkol S, Mikhailidis DP, Celik T, et al. Serum endocan levels as a marker of disease activity in patients with Behcet disease. J Am Acad Dermatol 2014;70:291–6
  14. Icli A, Cure E, Cure MC, Uslu AU, Balta S, Mikhailidis DP, et al. Endocan levels and subclinical atheroscl